RecallRadar

FDA Drug recall D-0991-2018

Enalapril Maleate, USP 5MG, 90-count bottle, RX only

On 2018-08-01 the FDA classified a Class III recall of Enalapril Maleate, USP 5MG, 90-count bottle, RX only by Aidarex Pharmaceuticals, citing out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0991-2018
ClassificationClass III
Statusterminated
Initiated2018-06-27
Published2018-08-01
Last updated2026-09-13 11:52 UTC
CompanyAidarex Pharmaceuticals
DistributionUS

Product

Enalapril Maleate, USP 5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India. NDC: 33261-0693-90

Reason

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Identifiers

code_info
Lots: 51904-1, EXP: 01/31/2018; 51904-4, 52885-1, EXP: 03/31/2018; 52885-3, EXP: 04/30/2018; 52885-4,EXP: 05/28/2018; 5…Lots: 51904-1, EXP: 01/31/2018; 51904-4, 52885-1, EXP: 03/31/2018; 52885-3, EXP: 04/30/2018; 52885-4,EXP: 05/28/2018; 53840-2,EXP: 5/28/2018; 53840-3, EXP:6/30/2018; 53840-4, EXP:8/31/2018; 56665-1, EXP: 01/31/2019; 58596-1, EXP: 05/28/2019.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0991-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.